PharVision Advisers’s Paycom PAYC Stock Holding History

PharVision Advisers’s Portfolio PAYC Stock Details PAYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,573	Closed	-$327K	–	924
2025 Q3	$327K	Buy	+1,573	New	+$354K	0.18%	175

Other funds holding PAYC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's PAYC Position: Q4 2025 in Review

PharVision Advisers sold out of Paycom (PAYC) in Q4 2025, closing a stake of 1,573 shares — an estimated $327K sold.

PharVision Advisers first reported a position in PAYC in Q3 2025 and held it in 1 quarter. The position peaked at $327K in Q3 2025. 717 funds tracked by Wall St. Rank hold PAYC as of Q4 2025.

PharVision Advisers reported no remaining Paycom position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,573 Paycom shares in Q4 2025, an estimated $327K.
PharVision Advisers first reported a position in Paycom in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Paycom position peaked at $327K in Q3 2025.
717 funds tracked by Wall St. Rank held Paycom as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.